Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2431743
Max Phase: Preclinical
Molecular Formula: C40H54N4O6
Molecular Weight: 686.89
Molecule Type: Small molecule
Associated Items:
ID: ALA2431743
Max Phase: Preclinical
Molecular Formula: C40H54N4O6
Molecular Weight: 686.89
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](OCCCCc3ccc4ccccc4c3)[C@H](N)C[C@@H]2N)[C@H](N)[C@@H](OCCCCc2ccc3ccccc3c2)[C@@H]1O
Standard InChI: InChI=1S/C40H54N4O6/c41-24-33-35(45)39(48-20-8-6-10-26-16-18-28-12-2-4-14-30(28)22-26)34(44)40(49-33)50-38-32(43)23-31(42)37(36(38)46)47-19-7-5-9-25-15-17-27-11-1-3-13-29(27)21-25/h1-4,11-18,21-22,31-40,45-46H,5-10,19-20,23-24,41-44H2/t31-,32+,33-,34-,35-,36-,37+,38-,39-,40-/m1/s1
Standard InChI Key: QKYDVHKVFANLIK-HFUCYITCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 686.89 | Molecular Weight (Monoisotopic): 686.4043 | AlogP: 3.29 | #Rotatable Bonds: 15 |
Polar Surface Area: 181.46 | Molecular Species: BASE | HBA: 10 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 10 | HBD (Lipinski): 10 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.81 | CX Basic pKa: 9.54 | CX LogP: 3.78 | CX LogD: -0.94 |
Aromatic Rings: 4 | Heavy Atoms: 50 | QED Weighted: 0.10 | Np Likeness Score: 0.76 |
1. Zimmermann L, Bussière A, Ouberai M, Baussanne I, Jolivalt C, Mingeot-Leclercq MP, Décout JL.. (2013) Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues., 56 (19): [PMID:24083676] [10.1021/jm401148j] |
2. Mingeot-Leclercq M, Decout J. (2016) Bacterial lipid membranes as promising targets to fight antimicrobial resistance, molecular foundations and illustration through the renewal of aminoglycoside antibiotics and emergence of amphiphilic aminoglycosides, 7 (4): [10.1039/C5MD00503E] |
3. Zimmermann L, Kempf J, Briée F, Swain J, Mingeot-Leclercq MP, Décout JL.. (2018) Broad-spectrum antibacterial amphiphilic aminoglycosides: A new focus on the structure of the lipophilic groups extends the series of active dialkyl neamines., 157 [PMID:30282323] [10.1016/j.ejmech.2018.08.022] |
Source(1):